Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Liposomal Bupivacaine Interscalene Nerve Block in Shoulder Arthroplasty: A Single Blinded Prospective Randomized Control Trial

NCT03663283 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT03663283
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03663283 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Liposomal Bupivacaine Interscalene Nerve Block in Shoulder Arthroplasty: A Single Blinded Prospective Randomized Control Trial
Lead sponsor
Mayo Clinic
Phase
Phase 4
Overall status
Completed
Start date
October 29, 2018
Completion date
February 14, 2020
Enrollment
104 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arthropathy shoulder